Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × OTHER × 68Ga-FAPI × Clear all

Phase

Status

Unknown 5 Recruiting 4 Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Radiotherapy 77 pembrolizumab 73 Cyclophosphamide 62 Cisplatin 57 Magnetic Resonance Spectroscopy 52 Gemcitabine 50 Radiosurgery 45 Carboplatin 45 Nivolumab 42 Paclitaxel 41 Fluorouracil 36 Biopsy 35 Dexamethasone 34 Bevacizumab 32 durvalumab 31 Oxaliplatin 31 Docetaxel 31 fludarabine 30 Radiation 29 Capecitabine 29 Surveys and Questionnaires 28 Leucovorin 28 fludarabine phosphate 25 Melphalan 25 Rituximab 24 Irinotecan 24 Cytarabine 24 Pemetrexed 23 Doxorubicin 23 Lenalidomide 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04023240 2024-08-12

68-Ga-FAPI PET Imaging in Malignancy

Stanford University

Phase 2 Withdrawn

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡